Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ca2-13-01194/USCOURTS-ca2-13-01194-0/pdf.json

Nature of Suit Code: 850
Nature of Suit: Securities, Commodities, Exchange
Cause of Action: 

---

1

13‐1194(L)

GAMCO v. Vivendi

UNITED STATES COURT OF APPEALS

FOR THE SECOND CIRCUIT

August Term 2015

(Argued: March 3, 2016    Decided: September 27, 2016)

No. 13‐1194(L), 13‐1377(XAP)

––––––––––––––––––––––––––––––––––––

GAMCO INVESTORS, INC., GAMCO GLOBAL SERIES FUNDS, INC., GABELLI CAPITAL

ASSET FUND, THE GABELLI VALUE FUND, INC., THE GABELLI ASSET FUND, THE

GABELLI GLOBAL MULTIMEDIA TRUST INC., THE GABELLI EQUITY TRUST, INC.,

Plaintiffs‐Appellants‐Cross‐Appellees,   

THE GAMCO MATHERS FUND, THE GABELLI CONVERTIBLE AND INCOME SECURITIES

FUND, INC., GAMCO INTERNATIONAL GROWTH FUND, INC.

Plaintiffs,   

‐v.‐ 

VIVENDI UNIVERSAL, S.A., VIVENDI S.A.,

Defendants‐Appellees‐Cross‐Appellants.

––––––––––––––––––––––––––––––––––––

Before:    CABRANES, LIVINGSTON, and LYNCH, Circuit Judges.   

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page1 of 21
2

Plaintiffs‐Appellants‐Cross‐Appellees, so‐called “value investors,” appeal

from the judgment of the United States District Court for the Southern District of

New York (Scheindlin, J.), granting judgment to the Defendants because they

had rebutted the fraud‐on‐the‐market presumption of reliance invoked by the

Plaintiffs as part of their claim under § 10(b) of the Securities Exchange Act of

1934, 15 U.S.C. § 78j(b).    For the reasons stated below, we AFFIRM the

judgment of the district court.

ANDREW J. ENTWISTLE, Entwistle & Cappucci LLP, New

York, N.Y. (Vincent R. Cappucci, Arthur V. Nealon,

Jordan A. Cortez, Entwistle & Cappucci LLP, New

York, N.Y., on the brief), for

Plaintiffs‐Appellants‐Cross‐Appellees.

MARK A. PERRY, Gibson, Dunn & Crutcher LLP,

Washington, D.C. (Miguel A. Estrada, Lucas C.

Townsend, Gibson, Dunn & Crutcher LLP, Washington,

D.C.; Caitlin J. Halligan, Gabriel K. Gillett, Gibson,

Dunn & Crutcher LLP, New York, N.Y.; James W.

Quinn, Gregory Silbert, Weil, Gotshal & Manges LLP,

New York, N.Y.; Daniel Slifkin, Timothy G. Cameron,

Cravath, Swaine & Moore LLP, New York, N.Y., on the

brief), for Defendants‐Appellees‐Cross‐Appellants.

PER CURIAM:

This appeal stems from the same set of underlying facts as those in In re

Vivendi S.A. Securities Litigation, Nos. 15‐180‐cv(L), 15‐208‐cv(XAP), in which we

have today issued a separate opinion.    Plaintiffs‐Appellants‐Cross‐Appellees

(collectively, “GAMCO”) are so‐called “value investors” who make their own

estimation of the value of a publicly‐traded company’s securities and attempt to

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page2 of 21
3

buy such securities when the market price is lower than its own valuation, betting

that the market price will rise over time.    Between 2000 and 2002, GAMCO

invested in the securities of Defendants‐Appellees‐Cross‐Appellants Vivendi

Universal, S.A. and Vivendi S.A. (collectively, “Vivendi”).    Thereafter, when the

nature of Vivendi’s liquidity situation came to light, the price of those securities

dropped dramatically.   

GAMCO subsequently brought a securities fraud action against Vivendi

under § 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”), 15 U.S.C.

§ 78j(b), as well as the Securities Exchange Commission’s (“SEC”) Rule 10b–5

(“Rule 10b–5”) promulgated thereunder, 17 C.F.R. § 240.10b–5.    After a bench

trial solely on the question whether Vivendi successfully rebutted the

fraud‐on‐the‐market presumption of reliance invoked by GAMCO to satisfy the

reliance element of its § 10(b) claim, see Basic Inc. v. Levinson, 485 U.S. 224, 247

(1988), the District Court for the Southern District of New York (Scheindlin, J.)

entered judgment for Vivendi.    See GAMCO Investors, Inc. v. Vivendi, S.A., 927 F.

Supp. 2d 88, 91 (S.D.N.Y. 2013) (“GAMCO”).    GAMCO now appeals.1

 1 Vivendi also cross‐appeals from the district court’s determination that Vivendi

was barred by collateral estoppel from contesting the other elements of GAMCO’s

§ 10(b) claim.    Because we affirm the district court’s decision in favor of Vivendi, we

need not reach this claim.

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page3 of 21
4

DISCUSSION

“On appeal from a bench trial, the district courtʹs findings of fact are

reviewed for clear error and its conclusions of law are reviewed de novo.”    Beck

Chevrolet Co., Inc. v. Gen. Motors LLC, 787 F.3d 663, 672 (2d Cir. 2015) (quoting

Mobil Shipping & Transp. Co. v. Wonsild Liquid Carriers Ltd., 190 F.3d 64, 67 (2d Cir.

1999)).   

To succeed on a § 10(b) and Rule 10b–5 claim, a plaintiff must prove “(1) a

material misrepresentation or omission by the defendant; (2) scienter; (3) a

connection between the misrepresentation or omission and the purchase or sale of

a security; (4) reliance upon the misrepresentation or omission; (5) economic loss;

and (6) loss causation.”    Halliburton Co. v. Erica P. John Fund, Inc., 134 S. Ct. 2398,

2407 (2014) (quoting Amgen Inc. v. Conn. Retirement Plans and Tr. Funds, 133 S. Ct.

1184, 1192 (2013)).    The traditional way a plaintiff demonstrates reliance is

directly, i.e. “by showing that he was aware of a company’s statement and

engaged in a relevant transaction . . . based on that specific misrepresentation.”   

Id. (quoting Amgen, 133 S. Ct. at 1192)).    However, a plaintiff may, in some

circumstances, invoke a “rebuttable presumption of reliance.”    Id. at 2408.    This

presumption rests on the “‘fraud‐on‐the‐market’ theory” which states “that ‘the

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page4 of 21
5

market price of shares traded on well‐developed markets reflects all publicly

available information, and, hence, any material misrepresentations.’”    Id.

(quoting Basic, 485 U.S. at 246).    Because “the typical ‘investor who buys or sells

stock at the price set by the market does so in reliance on the integrity of that

price’—the belief that it reflects all public, material information— . . . his ‘reliance

on any public material misrepresentations . . . may be presumed for purposes of a

Rule 10b–5 action.’”    Id. (quoting Basic, 485 U.S. at 247).    But the presumption, as

its name suggests, is rebuttable.2    “Any showing that severs the link between the

alleged misrepresentation and either the price received (or paid) by the plaintiff,

or his decision to trade at a fair market price, will be sufficient to rebut the

presumption . . . .”    Id. (quoting Basic, 485 U.S. at 248) (alteration omitted).   

As an initial matter, GAMCO argues that the District Court “erred in

concluding that . . . because Vivendi demonstrated that Plaintiffs are value

investors[,] Vivendi . . . proved [GAMCO] did not rely on the integrity of the

 2 To demonstrate successfully that the presumption should apply in a given case,

“a plaintiff must [show] . . . (1) that the alleged misrepresentations were publicly known,

(2) that they were material, (3) that the stock traded in an efficient market, and (4) that

the plaintiff traded the stock between the time the misrepresentations were made and

when the truth was revealed.”    Id.    It was not contested at the trial that the

presumption itself applied, only whether it had been rebutted.

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page5 of 21
6

market in purchasing Vivendi [securities].”    GAMCO Br. at 41.    According to

GAMCO, though it, like most value investors, does not believe that the market

price necessarily equals, at any given time, the efficient value of a security (and

thus makes its money by identifying under‐ or over‐valued securities), Halliburton

forecloses the conclusion that this fact alone suffices to rebut the presumption.3   

Vivendi, for its part, suggests that such a showing indeed suffices to rebut the

presumption.    See Vivendi Br. at 33; cf. Teamsters Loc. 445 Freight Div. Pension Fund

v. Bombardier Inc., 546 F.3d 196, 199 n.4 (2d Cir. 2008) (“The . . .

fraud‐on‐the‐market theory involves [the] rebuttable presumption[] . . .

‘that . . . investors rely on the market price of securities as an accurate measure of

their intrinsic value.’” (quoting Hevesi v. Citigroup Inc., 366 F.3d 70, 77 (2d Cir.

2004)).

It is true that the district court reasonably found facts that demonstrate that

GAMCO’s purchasing decisions relied in large part on an independent valuation

 3 See Halliburton, 134 S. Ct. at 2410 (“Debates about the precise degree to which

stock prices accurately reflect public information are . . . largely beside the point.”); id. at

2411 (noting that “there is no reason to suppose that . . . the value investor[] is as

indifferent to the integrity of market prices as Halliburton suggests”); but see id. (noting

that “Basic never denied the existence of [value] investors,” as “Basic concluded only that

‘it is reasonable to presume that most investors . . . will rely on the security’s market price

as an unbiased assessment of the security’s value in light of all public information.’”

(quoting Amgen, 133 S. Ct. at 1192)).   

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page6 of 21
7

of the worth of Vivendi’s securities that was separate and distinct from the market

price.    The district court found that GAMCO would begin by calculating a

“Private Market Value[]” (“PMV”) for a given security — a value that

approximated “the price that an informed industrialist would be willing to pay

for [the company], if each of its segments were valued independently in a private

market sale.”    GAMCO, 927 F. Supp. 2d at 94–95.    GAMCO would then

compare this PMV to the public market price.    If there was a sufficiently large

“spread between [the] PMV and the market price,” and if there was evidence of

the existence of a “catalyst,” id. at 94–96, or “some dynamic that [GAMCO

thought was] going to help surface value over time,” J.A. 359, then GAMCO

would generally elect to purchase the security in question.    Employees at

GAMCO often referred to its PMV as the “intrinsic value” of the stock, see, e.g.,

J.A. 338, 508, and frequently referred to the market price, in contrast, as reflecting

the whims of the sometimes “irrational . . . Mr. Market,” J.A. 358.

Though the district court indeed found that GAMCO does not necessarily

consider the market price to be an efficient reflection of the objective value of a

security at any given time, however, it explicitly disclaimed any reading of its

opinion as suggesting that this fact was sufficient, on its own, to rebut the

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page7 of 21
8

presumption.    See GAMCO, 927 F. Supp. 2d at 102 (“[O]ne can imagine a case

where an investor . . . used the market price of a security merely as a comparator

with a private method of valuation, but in which the fraud on the market

presumption could not fairly be rebutted, because, but for the material

misstatements, that investor would not have transacted in the securities at

issue.”).    We thus decline to explicate the contours of Halliburton here, further

theorize on the presumption, or otherwise address the relevance of the typical

value investing model to a rebuttal showing.    The district court’s holding was,

instead, based on a much narrower theory: that, given the facts in the record,

Vivendi proved that GAMCO would have purchased Vivendi securities even had

it known of Vivendi’s alleged fraud. See Halliburton, 134 S. Ct. at 2408 (observing

that a defendant may rebut the presumption by demonstrating, inter alia, “that a

plaintiff would have bought or sold the stock even had he been aware that the

stock’s price was tainted by fraud”); Kline v. Wolf, 702 F.2d 400, 403 (2d Cir. 1983)

(noting that the presumption may be rebutted through a showing “that plaintiffs

did not significantly rely on the integrity of the market or that, even if they had

known of the alleged misrepresentation, they would still have purchased the

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page8 of 21
9

stock”).4    GAMCO argues that this factual conclusion was error, and asserts that

“[i]t was clearly erroneous for the District Court to find that a sophisticated

 4 The district court found facts sufficient to establish that that it was more likely

than not that GAMCO would have purchased the relevant securities even if it had

known that Vivendi’s statements were misrepresenting its liquidity.    See GAMCO, 927

F. Supp. 2d at 97 (finding, inter alia, that “the liquidity crisis at Vivendi was irrelevant to

Plaintiffs’ investment decisions”). Nevertheless, GAMCO takes issue with the district

court’s approach to determining whether GAMCO would have purchased the security

even if it had known there was a fraud.    Specifically, GAMCO questions the district

court’s reliance on the argument that GAMCO would have considered Vivendi’s

securities a more attractive investment had Vivendi fully divulged its liquidity problems

to the entire market prior to GAMCO’s purchase.    See id. at 102 (where the district

court observes that “in this counterfactual scenario [where Vivendi did not commit any

fraud] . . . the price of Vivendi ADS’s would have been lower” as the market price

would have fallen with revelation of the truth, and thus “Plaintiffs would have seen

Vivendi as a more attractive investment”).    GAMCO does not necessarily question the

premise that, if Vivendi had fully disclosed its liquidity problems to the market, then

the market would likely have internalized the value of those problems, the stock’s price

would have fallen, and the spread between the PMV and the market price would thus

have been larger.    Nor does GAMCO deny that it may have purchased the security at

this lower price had there been no fraud at all.    Rather, GAMCO contests the relevance

of the district court’s inquiry to what GAMCO believes is the central issue, namely

whether GAMCO would have purchased shares “at the same price[]” had it been aware

that many of Vivendi’s statements were fraudulent.    Id. at 103 (emphasis added)

(internal quotation marks omitted); see also Halliburton, 134 S. Ct. at 2408 (noting that a

defendant may rebut the presumption by showing “that a plaintiff would have bought

or sold the stock even had he been aware that the stock’s price was tainted by fraud”).   

Though we observe that GAMCO’s framing of the appropriate inquiry has much

to recommend it, we need not conclusively endorse it here.    Even adopting, arguendo,

GAMCO’s preferred framing, see GAMCO Br. at 27 n.11 (acknowledging that the

presumption may be rebutted by showing that a “plaintiff would have purchased the

stock at the same price even if she had known of the fraud”), the district court did not

clearly err in concluding, as detailed herein, that revelation of Vivendi’s liquidity

problems would not have changed GAMCO’s purchasing decisions.   

   

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page9 of 21
10

financial manager would purchase securities in advance of undisclosed adverse

information which would have the predic[t]able impact of causing market prices

to decline.”    GAMCO Reply Br. at 8.    Our review of the record demonstrates

that it was not “clearly erroneous” for the district court to so conclude as to

GAMCO itself.    Under that deferential standard of review, we must accept the

district court’s findings of fact “unless we have a definite and firm conviction

that a mistake has been committed.”    Souratgar v. Lee, 720 F.3d 96, 103 (2d Cir.

2013) (internal quotation marks omitted).    We therefore need not, and do not,

decide whether we would have reached the same factual conclusions as the

district court.

First, though GAMCO repeatedly asserts on appeal that it is all but

unthinkable that a sophisticated investor would ever buy a security if he was

aware its market price might be tainted by fraud, the idea was not so ridiculous

to the Chief Investment Officer of Gabelli & Co.    Asked whether he would “buy

a stock in a company . . . [where he] knew . . . the price was inflated as a result of

a management fraud,” Mario Gabelli testified that such a purchase was

“possible, but very unlikely,” and clarified that he would “assign a 90‐10

probability” to such a scenario.    J.A. 530–31.    He went on to qualify this

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page10 of 21
11

statement, noting “[t]here would have to be a lot of other circumstances.”    Id. at

531.    The district court largely dismissed Gabelli’s testimony as “motivated

hairsplitting by an interested witness.”    GAMCO, 927 F. Supp. 2d at 94.    It is

thus highly significant that a prominent witness the district court believed was

exaggerating the facts in favor of the plaintiffs admitted on the stand that, in the

abstract, there was a ten percent possibility that, in a given case, he would buy

stock inflated by fraud.    Such testimony, at minimum, established — in contrast

to GAMCO’s repeated suggestions — that GAMCO had no ironclad policy

against purchasing a stock it believed might be inflated by fraud, provided that

other circumstances made the deal one worth pursuing.

To that end, the record in this case includes sufficient evidence supporting

the district court’s finding that such circumstances were present here: in other

words that, even if aware of Vivendi’s liquidity problems and its concealment of

those problems, GAMCO would still have believed the deal it made was a good

one.    As already noted, the district court reasonably found that the core of

GAMCO’s investment decisions could be reduced to two questions: first, was

there a material spread between market price and PMV, and second, was there

reason to believe a catalyst would cause the market to recognize this discrepancy

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page11 of 21
12

in the next two to five years.    Evidence in the record also supported the district

court’s conclusion that, had GAMCO known of the liquidity problems at Vivendi,

such knowledge would not have altered the answers to either of these questions.   

As to the spread, Andrew Rittenberry, the analyst primarily responsible for

calculating Vivendi’s PMV in the relevant period, testified that, once he learned of

the liquidity crisis at Vivendi (as the fraud came to light), the knowledge of the

liquidity problems had no “impact [on his] PMV calculation,” as he believed

those problems constituted “a short‐term issue . . . . [s]omething that could be

solved within a year or so.”    J.A. 401‐03. Rittenberry also testified that PMV was

generally calculated to anticipate the value of the company over the long haul.   

This testimony further supports the district court’s factual finding that GAMCO

would not have believed that a short‐term problem, especially one that it did not

perceive to be as significant as the market ultimately came to believe it was,

would affect its calculation of the spread.    See J.A. 368 (noting that, in calculating

the PMV, Rittenberry “projected the business performance of [the] differen[t]

pieces of the business over a five‐year period”); J.A. 383 (“[T]he goal in buying a

stock is to have it appreciate 50 percent over a two‐year period”); J.A. 527

(testimony of Mario Gabelli: “So the way we think is like a McKinsey thinking

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page12 of 21
13

out over the next five or ten years”). Thus, the record supports the district

court’s conclusion that, if GAMCO had known of the liquidity problems and

their concealment, GAMCO would still have believed Vivendi’s PMV to be

“materially higher” than the public market price.    J.A. 363.   

Second, it was also not clearly erroneous for the district court to conclude

that knowledge of Vivendi’s liquidity problems would not have changed

GAMCO’s belief that a catalyst was likely — i.e., its belief that the market price

would rise towards the PMV, if not immediately, then over the course of the next

several years.    Such evidence came in various forms.    First, GAMCO continued

to buy Vivendi securities as the full extent of Vivendi’s alleged fraud came to

light.    GAMCO argues that this information is hardly dispositive of whether

GAMCO would have purchased prior to the revelation of the fraud at the same

price at which it purchased (given that the revelation caused the market price to

fall as fraud‐induced inflation dissipated).    That may indeed be so, but the

evidence is specifically relevant to the narrower question whether knowledge of

the liquidity problems would have affected GAMCO’s belief in the existence of a

catalyst.    That GAMCO continued to buy reasonably suggested to the district

court that GAMCO still believed a catalyst to be on the horizon (and thus

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page13 of 21
14

demonstrated that the liquidity problems had not altered, and would not have

altered, this conclusion).    Further, Gabelli testified that a “change of

management” was one of the most frequent catalysts on which GAMCO would

rely in purchasing a stock.    J.A. 482.    This testimony further reinforced the

district court’s factual findings: had GAMCO known of the liquidity problems at

Vivendi (notwithstanding whether they had been fraudulently concealed), the

potential for a change in management would have seemed even more likely.   

In short, evidence in the record supported the district court in concluding

that, had GAMCO known of Vivendi’s liquidity problems, GAMCO would still

have believed, first, that Vivendi’s securities were substantially undervalued by

the market and second, that an event was likely to happen in the next few years

that would awaken the market to that fact.    Further, the record provided

sufficient evidence to find that GAMCO would have believed that, even if the

liquidity crisis in fact came to light, it would resolve within a short period of       

time — and thus, that even if the market price might go down in the short run,

the potential for long‐term profit still remained.    In other words, whereas one

can imagine situations in the abstract where a sophisticated investor, apprised of

a fraud, would necessarily conclude that a security was no longer a logical

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page14 of 21
15

purchase, the district court did not clearly err in concluding, on this record, that

in this case, and with regard to this particular fraud, GAMCO would still have

viewed Vivendi’s securities as a profitable investment — even if it might have

been concerned about the hidden liquidity risks.

GAMCO counters this extensive evidence by citing, almost exclusively, to

testimony of Andrew Rittenberry, which GAMCO employs to argue that the

district court’s factual findings were clearly erroneous.    Asked whether,

assuming the information “did not affect [his] PMV calculation, a liquidity crisis

would similarly not affect [his] buy, sell, or hold recommendation,” Rittenberry

replied, “[n]o, not necessarily.”    J.A. 401.    “The big driver,” he continued, “[is]

PMV.    But the discount to the PMV between the market price and the PMV is a

key factor.    If there is a liquidity crisis or some type of event like that, you

would expect the discount to widen.    I mean you would expect the stock to go

down.”    Id.    When further asked whether he “would expect the public market

price to go down,” Rittenberry answered, “[y]es.    You wouldn’t want to buy it

in front of that — if you thought it was going to go down, you would wait to buy

it or buy more or recommend to buy more at that point.”    Id.   

Pointing to Rittenberry’s testimony, GAMCO argues that even if it would

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page15 of 21
16

not have believed the liquidity problems to affect Vivendi’s PMV, and even if it

would still have believed it likely the investment would be profitable over the

long run, the record renders clearly erroneous the district court’s finding that it

would have purchased Vivendi’s securities had it known of the fraud.    This is

because, GAMCO argues, even if it indeed still thought Vivendi securities were

materially undervalued notwithstanding the crisis, it would have waited until

the liquidity crisis came to light and then bought the stock.    Such a delayed

purchase not only would have mitigated the risk associated with the undisclosed

liquidity problems (as fraud always creates some risk that the underlying

calculations are erroneous), but also would have potentially netted GAMCO a

more profitable investment.

It was not clearly erroneous, however, for the district court to find that

GAMCO would indeed have purchased Vivendi’s securities at the price quoted,

rather than simply await the potential of a public liquidity crisis.    First, both

Rittenberry’s testimony and GAMCO’s argument rest on the assumption that

Rittenberry (and GAMCO) would have known that the stock price would indeed

go down upon revelation of the liquidity crisis.    As already noted, however, the

district court reasonably found facts demonstrating that Rittenberry, or GAMCO,

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page16 of 21
17

apprised of the hidden liquidity risks, would not have been so certain.    At the

time GAMCO had to make its purchasing decision, even if it had known of the

fraud, it would not have been able to see the future.    And the record evidence as

to how GAMCO would have approached determining how likely it was that the

hidden risks would be exposed in a way that would materially affect the market

price does not support GAMCO’s position.   

Thus, Rittenberry testified that, when he did find out about the liquidity

problems, he believed that they constituted a very short‐term concern with

minimal impact on Vivendi’s value.    It was therefore not clearly erroneous for

the district court to infer that GAMCO, privy to this information prior to its

relevant purchases, would have believed it possible that the crisis would pass

without incident or public revelation, or at minimum be uncertain as to just how

the market would value the crisis were it to come to light.    Given that the record

makes clear that GAMCO would, in at least some circumstances, have purchased

a security even believing it was tainted by fraud, it is highly relevant that the

record also provides sufficient evidence to find that GAMCO would have

believed this particular fraud unlikely to become material.

Further, against this uncertainty of a future, hypothetical better deal, the

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page17 of 21
18

record provided evidence that GAMCO had reasons to believe the deal — which,

as already noted, would have appeared to be a good one — could get worse if

GAMCO waited.    As Rittenberry testified, the premise of GAMCO’s model was

that it found a stock was “trad[ing] at a discount to what [GAMCO believed] it[]

[was] worth temporarily,” and that “that discount [would] . . . narrow over time.”   

J.A. 357 (emphasis added).    As a general matter, then, to wait, rather than buy

the stock, always risked the possibility that the prophesied catalyst would come

early, or that the market would recognize that the value of the stock was

depreciated.    Further, Gabelli testified that he believed the market, in the

aggregate, to be “down sharply” by the beginning of 2001, J.A. 522, and in

GAMCO’s December 2000 Annual Report to investors, it “forecast . . . an

economic (and earnings) recovery” in “the second half of 2001” which would

“help[] . . . renew investor confidence and revive the market,” J.A. 591.    To wait

for the hypothetical revelation of the liquidity problems, then, would risk not

only that the market, specifically, would realize that Vivendi’s stock was

undervalued, but also that the market, generally, would rebound and the market

price would rise accordingly, sacrificing the spread.    It was not clearly

erroneous for the district court to conclude that GAMCO, aware of the fraud,

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page18 of 21
19

would not have waited to buy the securities.

In other words, the premise of Rittenberry’s testimony, and GAMCO’s

argument, assumes what it seeks to prove: that GAMCO would have known that

the liquidity problems would manifest in the way that, in hindsight, they

manifested, and would thus obviously have waited to buy if it purchased at all.   

But the district court’s rejection of that conclusion was not clearly erroneous.

Further, GAMCO exaggerates the probative value of Rittenberry’s testimony in

another way as well.    Even on its own terms, Rittenberry’s testimony does not

clearly suggest that GAMCO would not have bought if it had known of the

hidden liquidity risks.    Asked whether knowledge of such a hidden crisis

would “not affect” his buy or sell recommendation, Rittenberry, not unlike

Gabelli, answered equivocally: “no, not necessarily.”    J.A. 401 (emphasis added).   

And, when describing what his recommendation would be, he did not say that he

would recommend that GAMCO not buy; instead, he testified that “if [he]

thought [the market price] was going to go down, [he] would wait to buy it or

buy more or recommend to buy more at that point.”    Id. (emphasis added).    In other

words, the district court did not have to read this testimony as GAMCO reads it.   

Instead, it could reasonably have read Rittenberry’s testimony as suggesting that

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page19 of 21
20

GAMCO would buy and then wait and buy more if indeed the liquidity problems

surfaced.    Such an approach would potentially allow GAMCO to ensure it

captured a good deal when it saw one while hedging against the possibility of an

uncertain future.

It may seem unlikely, in the abstract, that an investor, aware of fraud,

would opt to purchase a given security.    Nevertheless, after a trial, we do not

review a district court’s factual findings for whether they seem, in the abstract,

correct — we review the record for sufficient evidence in support of those

judgments.    And here, the record at the trial simply does not establish that it

was clearly erroneous for the district court to find that GAMCO, had it known of

the liquidity problems at Vivendi, would have made the choice to buy the same

securities it purchased.5    

 5 We also conclude that GAMCO’s challenge to the district court’s grant of

summary judgment is unreviewable.    GAMCO concedes that we do not have

jurisdiction to hear an appeal from a denial of summary judgment after a trial, unless

the “district court’s error was purely one of law.”    Stampf v. Long Island R.R. Co., 761

F.3d 192, 201 n.2 (2d Cir. 2014); see GAMCO Reply Br. at 31–32.    GAMCO further

acknowledges that one ground on which the district court denied summary judgment

was its finding that “GAMCO could possibly have uncovered non‐public corrective

information which would rebut the presumption of reliance.”    GAMCO Br. at 9; see also

J.A. 92.    GAMCO concedes that, as a legal matter, this scenario does indeed rebut the

presumption of reliance.    See GAMCO Br. at 27 n.11 (noting that one of the

“recognized ways to rebut the . . . presumption [is when] plaintiff possessed non‐public

information concerning the fraudulent misstatements.”).    GAMCO argues that

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page20 of 21
21

CONCLUSION

Accordingly, and finding no merit in the Plaintiffs’ remaining arguments,

we AFFIRM the judgment of the District Court.

 

evidence in the record created no material question of fact, at summary judgment,

whether GAMCO had such information. This argument misses the point.    To the

degree that GAMCO agrees with the legal standard the district court applied

(non‐public corrective information can rebut the presumption of reliance) and argues

only that the district court erred in finding a material question of fact pursuant to that

legal standard, at least one ground for the district court’s denial of summary judgment

was not a pure error of law, but one of fact.    Thus, the denial is not reviewable by this

Court.    See Stampf, 761 F.3d at 201 n.2.

Case 13-1194, Document 191-1, 09/27/2016, 1871338, Page21 of 21